We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$12.9B
AUM Growth
-$678M
Cap. Flow
+$6.37M
Cap. Flow %
0.05%
Top 10 Hldgs %
23.8%
Holding
3,083
New
921
Increased
335
Reduced
1,799
Closed
24

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$60.7M
2
MDT icon
Medtronic
MDT
+$35.8M
3
AAPL icon
Apple
AAPL
+$30.8M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
LIN icon
Linde
LIN
+$24.3M

Sector Composition

Rank Sector Weight
1 Technology 24.64%
2 Financials 13.28%
3 Healthcare 13.15%
4 Consumer Discretionary 12.03%
5 Industrials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HY icon
2576
Hyster-Yale Materials Handling
HY
$599M
$40K ﹤0.01%
+1,208
New +$47.7K
LEU icon
2577
Centrus Energy
LEU
$3.48B
$40K ﹤0.01%
+1,173
New +$49.3K
NDLS icon
2578
Noodles & Co
NDLS
$111M
$40K ﹤0.01%
+830
New +$50.9K
TNK icon
2579
Teekay Tankers
TNK
$2.75B
$40K ﹤0.01%
+2,883
New +$35K
VSTM icon
2580
Verastem
VSTM
$510M
$40K ﹤0.01%
2,346
-190
-7% -$3.27K
NPKI
2581
NPK International
NPKI
$1.06B
$40K ﹤0.01%
10,921
-832
-7% -$3.09K
CINC
2582
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$40K ﹤0.01%
+2,271
New +$46.6K
ATRO icon
2583
Astronics
ATRO
$3.43B
$39K ﹤0.01%
+3,619
New +$39.4K
BLUE
2584
DELISTED
bluebird bio
BLUE
$39K ﹤0.01%
+407
New +$53.7K
PRCT icon
2585
Procept Biorobotics
PRCT
$1.06B
$39K ﹤0.01%
+1,124
New +$27K
UTMD icon
2586
Utah Medical Products
UTMD
$225M
$39K ﹤0.01%
+433
New +$39.8K
NESR
2587
National Energy Services Reunited Corp
NESR
$2.72B
$39K ﹤0.01%
+4,591
New +$43.7K
DICE
2588
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$39K ﹤0.01%
+2,029
New +$36.2K
LUNA
2589
DELISTED
Luna Innovations Incorporated
LUNA
$39K ﹤0.01%
+5,040
New +$36.2K
FHTX icon
2590
Foghorn Therapeutics
FHTX
$266M
$38K ﹤0.01%
+2,501
New +$34.3K
FNLC icon
2591
First Bancorp
FNLC
$396M
$38K ﹤0.01%
+1,252
New +$39.1K
HBIO icon
2592
Harvard Bioscience
HBIO
$27.5M
$38K ﹤0.01%
+620
New +$36.7K
MELI icon
2593
Mercado Libre
MELI
$95.2B
$38K ﹤0.01%
+32
New +$34.8K
MLR icon
2594
Miller Industries
MLR
$573M
$38K ﹤0.01%
+1,367
New +$42.1K
RUSHB icon
2595
Rush Enterprises Class B
RUSHB
$6.04B
$38K ﹤0.01%
+1,174
New +$39K
SSTI icon
2596
SoundThinking
SSTI
$100M
$38K ﹤0.01%
+1,385
New +$37.7K
VTGN icon
2597
VistaGen Therapeutics
VTGN
$9.89M
$38K ﹤0.01%
1,012
-80
-7% -$3.49K
FMTX
2598
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$38K ﹤0.01%
+4,107
New +$43.7K
COGT icon
2599
Cogent Biosciences
COGT
$6.65B
$37K ﹤0.01%
+4,942
New +$34.4K
CTRN icon
2600
Citi Trends
CTRN
$555M
$37K ﹤0.01%
+1,199
New +$56K

Similar funds

Amalgamated Bank's Q1 2022 Portfolio in Review

As of Q1 2022, Amalgamated Bank held 3,083 positions worth $12.9B, down 5% from $13.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Amalgamated Bank's Q1 2022 filing shows 921 new, 335 increased, 1,799 reduced and 24 closed positions. Its largest new stake was Accenture: 180,111 shares worth $60.7M. The largest sale was iShares Core S&P 500 ETF, an estimated $21M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Amalgamated Bank's largest Q1 2022 buy was Accenture: 180,111 shares worth $60.7M.
  • Amalgamated Bank added most to Apple in Q1 2022, an estimated $30.8M increase.
  • Amalgamated Bank's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21M.
  • Amalgamated Bank fully exited iShares Russell 3000 ETF in Q1 2022, selling an estimated $15.3M.
  • Amalgamated Bank's ten largest holdings make up 24% of its $12.9B portfolio in Q1 2022.
  • Amalgamated Bank opened 921 new positions and closed 24 in Q1 2022.
  • Amalgamated Bank's portfolio value fell 5% quarter-over-quarter to $12.9B.

Based on Amalgamated Bank's 13F filing for Q1 2022, filed 30 Jun 2022.